Latest News and Press Releases

EDMONTON, Alberta, March 27, 2023 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced positive topline results from NATALEE (TRIO033), a Novartis sponsored Phase III trial...

-El 100% de los empleados considera que TRIO Uruguay es un gran lugar para trabajar- MONTEVIDEO, Uruguay, April 11, 2022 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), una...

-100% dos funcionários consideram o TRIO Uruguai um ótimo lugar para trabalhar- MONTEVIDÉU, Uruguai, April 11, 2022 (GLOBE NEWSWIRE) -- A Translational Research in Oncology (TRIO), uma...

-100% of employees consider TRIO Uruguay a great place to work- MONTEVIDEO, Uruguay, April 11, 2022 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global oncology clinical...

- Third Time Named to Alberta’s Top Employer List - EDMONTON, April 06, 2022 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO), a global academic clinical research organization, is...

EDMONTON, Alberta, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of first patient in the...

EDMONTON, Alberta, July 06, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment completion in coopERA...

EDMONTON, Alberta, May 20, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced the appointment of Prof. Seock-Ah Im...

EDMONTON, Alberta, April 21, 2021 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced completion of enrollment for Novartis phase III clinical trial of ribociclib with...

EDMONTON, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, is pleased to be recognized as one of Alberta’s Top...